Raymond James & Associates’s Global X Funds Global X HealthTech ETF HEAL Stock Holding History
Bought
Maintained
Sold
Other funds holding HEAL
WWA
IA
IFPG
Raymond James & Associates's HEAL Position: Q3 2024 in Review
Raymond James & Associates reduced its Global X Funds Global X HealthTech ETF (HEAL) stake by 8.4% in Q3 2024, selling an estimated $17K and leaving 6,696 shares worth $201K. The position accounts for ﹤0.01% of the portfolio, ranked #3636.
Raymond James & Associates first reported a position in HEAL in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.3M in Q2 2021. 36 funds tracked by Wall St. Rank hold HEAL as of Q3 2024.
- Raymond James & Associates held 6,696 shares of Global X Funds Global X HealthTech ETF worth $201K as of Q3 2024.
- Raymond James & Associates sold 616 Global X Funds Global X HealthTech ETF shares in Q3 2024, an estimated $17K.
- Global X Funds Global X HealthTech ETF made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #3636 holding.
- Raymond James & Associates first reported a position in Global X Funds Global X HealthTech ETF in Q4 2020 and has held it in 16 quarters since.
- Raymond James & Associates's Global X Funds Global X HealthTech ETF position peaked at $1.3M in Q2 2021.
- 36 funds tracked by Wall St. Rank held Global X Funds Global X HealthTech ETF as of Q3 2024.
Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.